Acrospire Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,671
| Closed | -$72K | – | 1252 |
|
|
2017
Q2 | $72K | Sell |
1,671
-2,501
| -60% | -$108K | 0.07% | 505 |
|
|
2017
Q1 | $131K | Sell |
4,172
-4,998
| -55% | -$157K | 0.11% | 171 |
|
|
2016
Q4 | $232K | Buy |
9,170
+3,918
| +75% | +$99.1K | 0.1% | 264 |
|
|
2016
Q3 | $130K | Sell |
5,252
-3,000
| -36% | -$74.3K | 0.09% | 355 |
|
|
2016
Q2 | $168K | Buy |
8,252
+2,052
| +33% | +$41.8K | 0.12% | 149 |
|
|
2016
Q1 | $95K | Buy |
+6,200
| New | +$95K | 0.07% | 354 |
|